Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000947871-11-000012
Filing Date
2011-01-03
Accepted
2011-01-03 21:48:49
Documents
1
Period of Report
2011-01-01

Document Format Files

Seq Description Document Type Size
1 ss108524_3.html 3  
1 ss108524_3.xml 3 10628
  Complete submission text file 0000947871-11-000012.txt   13597
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 11503189

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 11503188

Mailing Address 787 THIRD AVENUE 30TH FL NEW YORK NY 10017
Business Address 787 THIRD AVENUE 30TH FL NEW YORK NY 10017 212-749-6400
OrbiMed Capital GP III LLC (Reporting) CIK: 0001432241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 11503187